Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Nondysplastic Crypts in Fission in Nonpolypoid Adenomas and in the Adjacent Mucosa Support Field Cancerization in the Colon

CARLOS A. RUBIO and PETER T. SCHMIDT
Anticancer Research March 2021, 41 (3) 1515-1521; DOI: https://doi.org/10.21873/anticanres.14910
CARLOS A. RUBIO
1Gastrointestinal Research Laboratory, Department of Pathology, Karolinska Institute and University Hospital, Stockholm, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Carlos.Rubio@ki.se
PETER T. SCHMIDT
2Department of Medicine (Solna), Karolinska Institute and Ersta Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: We recently noticed in nonpolypoid adenomas (NPA) and the adjacent normal mucosa, nondysplastic crypts in symmetric and asymmetric fission (NDCSAF). Patients and Methods: All NDCSAF found in 80 small NPA and in the adjacent mucosa were registered. Results: A total of 178 NDCSAF (mean, 2.2) were found: 12 (6.7%) interspersed between adenomatous glands, 36 (20.2%) partially replaced by dysplastic epithelium, and 130 (73%) underneath the adenomatous tissue. Of the 61 cases with normal mucosa adjacent to NPA, 40 (65.6%) disclosed NDCSAF, and the remaining 21 (34.4%) normal crypts, exclusively. Conclusion: The accruing of NDCSAF within NPA and surrounding mucosa, are outstanding findings. Given that colonic crypts may undergo only one fission every 30-40 years, the accruing of NDCSAF in and about small NPA reveals mucosal hubs with pathological aberrations of cryptogenesis, probably conveyed by somatic mutations. The findings support the existence of field cancerization in the colonic mucosa.

Key Words:
  • Colon
  • field cancerization
  • nonpolypoid conventional adenomas
  • symmetric crypt fission
  • asymmetric crypt fission

The mean total length of the human colon is 160.5 cm (1), and the total mucosal area (2) is 995 cm2. This vast mucosal area is built of anthemic folds (3) and innominate grooves (4, 5). In well-oriented sections, anthemic folds consist of an assemblage of mucosal invaginations called glands or crypts, aligned as parallel “test tubes” (6). The creation of a new crypt is attained by symmetric fission, beginning at the base of the crypt. The bifurcation progresses upwards until two identical individual crypts are finally formed. Crypt fission reaches its peak during early infancy (7), but in adults, crypt fission is rarely seen (8-10). In a previous study of histological sections from 22 normal colonic segments, proximal or distal to surgically removed colonic carcinoma (11), we recorded all crypts present in 15 continuous fields of view, corresponding to 30 mm of colonic mucosa. A total of 8,580 crypts were found in the 22 controls (mean: 390 crypts/segment, range=382-408). Crypts with normal shapes and normal epithelium were present in all 22 colonic segments. Nonetheless, in three of the segments, few crypts with irregular architecture, including occasional crypts in symmetric fission, were present. Importantly, crypts in asymmetric fission were not found (11). This huge colonic mucosal area is relentlessly exposed to a cocktail of risk factors able to set aflame the chain of molecular events that generate epithelial dysplasia and eventually invasive carcinoma. The main risks factors leading to this development are: i) Genetic differences [the risk is higher in patients with germline mutations in one of the DNA mismatch repair genes (MMR)] (12), ii) Gender (the risk is higher in males) (13), iii) Obesity (physical inactivity and obesity are strong independent determinants associated to colon cancer) (14), iv) Type 2 diabetes (hyperinsulinaemia is important in the pathogenesis of colon cancer) (15), v) Environmental carcinogens, such as polycyclic aromatic hydrocarbon (16), vi) Mutant gut microbiome (17), vii) The breakdown of the gut macrophage-barrier (allowing the trespassing of the gut-microbiome into the host, thereby destabilizing host immunity) (18), viii) Epigenetic alterations (addition or deletion of methylated groups or changes in the histones that bind DNA to chromosomes) (19), and ix) Life style factors (alcohol and tobacco, encourage the development of sessile serrated lesions) (20). Given that the entire colorectal mucosa is relentlessly exposed to one or several of the aforementioned risks factors, the pertinent questions are: i) Why the aforementioned factors only trigger carcinogenesis in a small mucosal domain, leading to the evolution of nonpolypoid adenomas (as well as sporadic polypoid adenomas, traditional serrated adenomas or sessile serrated adenomas)? In this regard, Konishi and Morson (21) found in a series of 1,241 adenomas, that 50% had only one adenoma, and Griffioen et al. (22) found in 124 patients, that 60% had a single adenoma. Colon carcinomas also evolve as solitary lesions; synchronous multiple colon cancers are rare. Drew et al. (23) found among 134,305 individuals, 1,981 solitary colorectal cancers (CRC) but only 45 synchronous CRC, and ii) Why the remnant colorectal mucosa in patients harbouring an adenoma or a carcinoma remains refractory to the growth of similar lesions elsewhere in the colon, despite that this mucosa has unremittingly been subjected to the same risk factors?

Exploring that crucial conundrum, Slaughter et al. (24) proposed, 67 years ago, the concept of “field cancerization”. Field cancerization (also called field defects, field effect, or field of susceptibility) refers to the cellular and molecular alterations triggering initiation, evolution, and progression to neoplastic transformation in the large mucosal domain. In later years, the concept of field cancerization of the colonic mucosa has received much attention (25-27). In the mucosa adjacent to CRC, Filipe found altered mucus secretion (28). That “transitional” mucosa, as it was called, often had increased sialomucins, and decreased or absent sulphomucins, with goblet cells being increased in number and size. Filipe suggested that the changes in the mucin secretion around CRC reflected a transformation to a fetal epithelium, corresponding to an early stage in carcinogenesis (28). TEM studies of the transitional mucosa revealed electron-dense bodies, 0.15-0.3~m in diameter, and an elaborated and enlarged Golgi zone with increased secretory activity (29). It was suggested that mucin (light microscopy) and ultrastructural (TEM) changes in the “transitional” mucosa of CRC, highlighted a failure in the normal process of cell differentiation along the crypt (29). Subsequently, other changes were recorded in the mucosa surrounding CRC, such as loss of the peripheral nuclear heterochromatin (30), deficient expression of DNA repair enzymes (31), increased folate concentrations and reduction of aberrant DNA (27), biological changes (32-34), abnormal gene expression (35), FHL1 on chromosome X (36), mutations of the K-ras codon 12 (37), and Type 2 diabetes mellitus (38). In contrast, there are no previous studies dealing with histologic aberrations occurring in the mucosa bordering small nonpolypoid colon adenomas, except for a substantial crypt elongation of the proximate zone mucosa to flat adenoma, reported by Kristt et al. (39).

Recently, while reviewing sections from endoscopically-resected small nonpolypoid adenomas, we observed in the non-dysplastic mucosa adjacent to nonpolypoid adenomas, crypts in symmetric and in asymmetric fission (40).

The purpose of the present survey was to report the frequency of the non-dysplastic crypts in symmetric and asymmetric fission (NDCSAF) found within a cohort of nonpolypoid colon adenomas and in their adjacent nondysplastic mucosa.

Patients and Methods

Histologic sections from 80 consecutive small nonpolypoid conventional adenomas (<1 cm in diameter) were retrieved from the archives of the Department of Pathology. Particular attention was paid to the nondysplastic colon mucosa adjacent to the neoplastic adenomatous tissue. Nonpolypoid lesions were endoscopically removed by mucosectomy, and immersed in formalin for 24 h. At the laboratory, the mucosectomy was cut in approximately two mm broad fractions, and transferred to paraffin wax blocks. Sections were cut at 4 μm and stained with hematoxylin and eosin (H&E).

Histological evaluation. All 80 small nonpolypoid lesions were tubular adenomas: 69 (86.3%) had low-grade dysplasia, and the remaining 11 (13.8%) high-grade dysplasia. The nondysplastic colon mucosa neighbouring nonpolypoid conventional adenomas was present in 61 cases and missing in the remaining 19 cases.

Definitions

I) Nondysplastic colonic crypts in symmetric fission in well-oriented sections: Twin upright crypts sharing a single luminal opening on top.

II) Nondysplastic colonic crypts in asymmetric fission in well-oriented sections: Two or more upright, disimilar crypts, sharing a single luminal opening on top.

III) Nondysplastic colonic crypts in symmetric fission in cut-across sections: Twin, back-to-back, symmetric “ring-shaped” crypts, joined by a thin epithelial rim. This grouping has been referred to as the back-to-back sign in UC (8).

IV) Nondysplastic colonic crypts in asymmetric fission in cut-across sections: Two or more back-to-back “ring-shaped” crypts varying in diameter and/or shape, joined by a thin epithelial rim.

Ethical approval. The Regional Ethical Review Board in Stockholm approved this study (Dnr 2018-2024/32).

Results

Of the 61 cases having colon mucosa adjacent, 40 NPA (65.6%) revealed 75 NDCSAF (mean: 1.9) interspersed between apparently normal crypts. The mucosa in the vicinity of the remaining 21 NPA (34.4%), showed normal crypts arranged in a “test tube” fashion, lacking NDCSAF.

Nondysplastic crypts in symmetric fission in the vicinity to NPA. All 40 cases (100%) displayed crypts in symmetric fission in the mucosa neigbouring NPA: a single crypt in symmetric fission was seen in 24 cases, two crypts in symmetric fission in 10, and three crypts in symmetric fissision in six cases. In all, a total of 62 crypts in symmetric fission were found in the nondysplastic mucosa neigbouring the 40 NPA (mean: 1.6) (Figure 1B).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Images of nondysplastic crypts in asymmetric and symmetric fissions. A: Crypts in fission in the nondysplastic mucosa (pointers) surrounding a nonpolypoid colon adenoma (H&E, original ×4). B: Crypts in symmetric fission in the nondysplastic mucosa surrounding a nonpolypoid colon adenoma (H&E, original ×4). C: Nondysplastic mucosa in the vicinity of a nonpolypoid colon adenoma. Note nondysplastic crypts in asymmetric fission (arrows) (H&E, original ×10). D: Closer view exposing a crypt in asymmetric fission (arrows) in the nondysplastic mucosa neighbouring a nonpolypoid colon adenoma, (H&E, original ×20). E: Interspersed nondysplastic crypts in asymmetric fission (arrows), amid dysplastic crypts of a nonpolypoid adenoma (H&E, original ×10). F: Closer views showing crypts in asymmetric fission (arrows) being replaced by down-growing dysplastic epithelium (H&E, original ×20). G: Crypts in asymmetric fission beneath the neoplastic canopy of a small nonpolypoid colon adenoma (H&E, original ×10).

Nondysplastic crypts in asymmetric fission in the vicinity to NPA. In the neigbouring mucosa, nine cases (22.5%) of the 40 NPA had crypts in asymmetric fission: a single crypt in asymmetric fission was found in six cases, two crypts in asymmetric fission in two, and three crypts in asymmetric fission in the remaining one. All together, 13 crypts in asymmetric fission were recorded in the nondysplastic mucosa adjacent to the 40 NPA (mean: 0.33) (Figure 1A, C, and D).

Nondysplastic crypts in symmetric fission inside NPA (Table I).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Total number of crypts in fission in 80 nonpolypoid colon adenomas.

i) Crypts in symmetric fission interspersed with dysplatic glands were found in six NPA: a single crypt in symmetric fission was found in four NPA, and two crypts in symmetric fission in two NPA. In all, eight crypts in symmetric fission interspersed with dysplatic glands were recorded in the 80 NPA (mean: 1.3 crypts) (Figure 1E).

ii) Symmetric crypts partially replaced by dysplastic epithelium were detected in 16 NPA: a single symmetric crypt was seen in 11 NPA, and two symmetric crypts in five NPA. In all, a total of 21 symmetric crypts partially replaced by dysplastic epithelium were found in the 16 NPA (mean: 1.3 crypts/NPA) (Figure 1F).

iii) Crypts in symmetric fission were also present beneath the dysplastic compartment in 39 NPA: a sigle crypt in symmetric fission was found in 16 NPA, two symmetric crypts in 14 NPA and three symmetric crypts in nine NPA. Taken together, the total number of crypts in symmetric fission beneath the dysplastic compartment was 71 in the 39 NPA (mean: 1.8) (Figure 1G).

Nondysplastic crypts in asymmetric fission inside NPA (Table I).

i) Nondysplastic crypts in asymmetric fission interspersed with dysplatic glands were found in three NPA: a single crypt in asymmetric fission was found in two NPA, and two crypts in asymmetric fission in one NPA. In all, four crypts in asymmetric fission were recorded interspersed with dysplatic glands in the three NPA (mean: 1.3).

ii) Asymmetric crypts partially replaced by dysplastic epithelium were detected in 12 NPA: a single asymmetric crypt was seen in nine NPA, and two asymmetric crypts, in three NPA. In total, a total of 15 asymmetric crypts partially replaced by dysplastic epithelium were found in 12 NPA (mean: 1.3 crypts/NPA).

iii) Crypts in asymmetric fission were also present beneath the dysplastic compartment in 33 NPA: a sigle crypt in asymmetric fission was found in 14 NPA, two asymmetric crypts in 12 NPA and three asymmetric crypts in seven NPA. Taken together, the total number of crypts in asymmetric fission beneath the dysplastic compartment was 59 in 33 NPA (mean: 1.0).

Discussion

The results of this survey indicate that nonpolypoid adenomas often exhibit NDCSAF, either sandwhiched amongst dysplastic crypts, beneath the neoplastic canopy of nonpolypoid adenomas (40) or are partially replaced by downward-growing dysplastic cells (41, 42). Importantly, NDCSAF were ofen seen in the adjacent, apparently normal mucosa surrounding NPA. A plausible explanation for these findings might be that NPA initially evolved on a restricted mucosal domain consisting of nondysplastic crypts in symmetric and in asymmetric fission. Bearing in mind that in the normal mucosa of adults, crypts in symmetric fission are rarely found (10, 11, 43, 44), and that crypts in asymmetric fission never occur, the present findings revealed abnormally increased cryptogenesis, some with pathologic aberration, as in those with asymmetric fission in and about NPAs.

Today, the histologic pathway of sporadic colon carcinogenesis, also referred to as the adenoma-carcinoma sequence (45), is known to be preceded by cytologic aberrations such as low-grade dysplasia, high-grade dysplasia, and often, by structural villous changes before invasive cancer ensues. These steps are driven by a series of molecular alterations, leading to the accumulation of genomic aberrations, chromosome-instability and microsatellite-instability (46-49). Notwithstandig, it remains elusive why the aforementioned molecular alterations leading to histologic neoplastic changes only affect a limited mucosal domain in the colon and not the entire mucosa.

The repopulation of the crypts is synchronized by stem cells (50-52). The stem cell niche, located at the crypt base, maintains cell number homeostasis in the colonic crypts. Wnt signaling controls cell proliferation, differentiation and apoptosis along the crypts; Wnt concentration is high at the bottom of the crypt (where stem cells reside) and low at the top. In contrast, APC concentration is low at the crypt bottom and high at the top (where differentiated cells reside) (50, 51). Wnt signaling has been linked to crypt fission, being required for the production of colon crypts in infant rats and in mice in vitro (52, 53). Given that colonic crypts may only undergo one fission event every 30-40 years (54), the demonstration of nondysplastic crypts in symmetric fission accruing within the confines of nonpolypoid adenomas and their adjacent mucosa, strongly suggest increased abnormal cryptogenesis in limited mucosal hubs. The finding of nondysplastic crypts in asymmetric fission in the same area suggest that the abnormal cryptogenesis might be possibly generated by putative somatic mutations. The possibility that the pathological cryptogenesis might be linked with the susceptibility of these crypts to develop dysplastic changes cannot be totally rejected. If this is the case, then those small mucosal domains would fulfill the requirements of Slaughter’s postulate (24).

In summary, NDCSAF were found: i) In the nondysplastic mucosa adjacent to NPA, ii) Intercalated between the adenomatous glands, iii) Beneath the adenomatous glands and iv) Replacing the dysplastic epithelium in a top-down maner (41). Given that colonic crypts may undergo only one fission every 30-40 years (54), the demonstration of nondysplastic crypts in asymmetric fission, within the confines of small NPA and in their vicinity, strongly suggest pathological aberrations of cryptogenesis, most probably conveyed by somatic mutations.

The present survey supports the concept of field cancerization (24) in the colon.

Footnotes

  • Authors’ Contributions

    CAR collected the initial data, reviewed the sections, and wrote the original draft. PTS obtained the permission of The Regional Ethical Review Board in Stockholm, Sweden, revised the original draft and introduced valuable suggestions.

  • Conflicts of Interest

    The Authors have no conlficts of interest to declare regarding this study.

  • Received January 14, 2021.
  • Revision received January 23, 2021.
  • Accepted January 25, 2021.
  • Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

References

  1. ↵
    1. Hounnou G,
    2. Destrieux C,
    3. Desmé J,
    4. Bertrand P and
    5. Velut S
    : Anatomical study of the length of the human intestine. Surg Radiol Anat 24: 290-294, 2002. PMID: 12497219. DOI: 10.1007/s00276-002-0057-y
    OpenUrlCrossRefPubMed
  2. ↵
    1. Nguyen H,
    2. Loustaunau C,
    3. Facista A,
    4. Ramsey L,
    5. Hassounah N,
    6. Taylor H,
    7. Krouse R,
    8. Payne CM,
    9. Tsikitis VL,
    10. Goldschmid S,
    11. Banerjee B,
    12. Perini RF and
    13. Bernstein C
    : Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer. J Vis Exp 41: 1931-1936, 2010. PMID: 20689513. DOI: 10.3791/1931
    OpenUrlCrossRef
  3. ↵
    1. Filipe MI
    : The mucous membrane of the normal human large intestine and the changes which occur in it immediately adjacent to proven carcinoma- A histochemical, autoradiographic and chemical study. PhD Thesis, University of London, 1971.
  4. ↵
    1. William I
    : Innominate grooves in the surface of mucosal. Radiology 84: 877-880, 1965. PMID: 14282698. DOI: 10.1148/84.5.877
    OpenUrlCrossRefPubMed
  5. ↵
    1. Levine DS and
    2. Haggitt RC
    : Normal histology of the colon. Amer J Surg Pathol 3: 966-984, 1989. PMID: 2679155. DOI: 10.1097/00000478-198911000-00008
    OpenUrlCrossRef
  6. ↵
    1. Rubio CA
    : Innominate grooves of the colon: Histological reappraisal. Anticancer Res 40: 7031-7035, 2020. PMID: 33288599. DOI: 10.21873/anticanres.14729
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Cummins A,
    2. Catto-Smith A,
    3. Cameron D,
    4. Couper R,
    5. Davidson, Day A,
    6. Hammond P,
    7. Moore D and
    8. Thompson F
    : Crypt fission peaks early during infancy and crypthyperplasia broadly peaks during infancy and childhood in the small intestine of humans. J Pediatr Gastroenterol Nutr 47: 153-157, 2008. PMID: 18664866. DOI: 10.1097/MPG.0b013e3181604d27
    OpenUrlCrossRefPubMed
  8. ↵
    1. Dawson PA and
    2. Filipe MI
    : An ultrastructural and histochmical study of the mucous membrane adjacnt to and remote from carcinoma of the colon. Cancer 37: 2388-2398, 1976. PMID: 177188. DOI: 10.1002/1097-0142(197605)37:5<2388::aid-cncr2820370531>3.0.co;2-9
    OpenUrlCrossRefPubMed
    1. Gostieva E V and
    2. Thilly WG
    : Stem cell stages and the origins of colon cancer: a multidisciplinary perspective. Stem Cell Rev 1: 243-51, 2005. PMID: 17142861. DOI: 10.1385/SCR:1:3:243
    OpenUrlCrossRefPubMed
  9. ↵
    1. Cheng H,
    2. Bjerknes M,
    3. Amar J and
    4. Gradiner G
    :. Crypt production in normal and diseased human colonic epithelium. Anat Rec 216: 44-48, 1986. PMID: 3094402. DOI: 10.1002/ar.1092160108
    OpenUrlCrossRefPubMed
  10. ↵
    1. Rubio C A and
    2. Schmidt PT
    : Are non-dysplastic crypts with corrupted shapes the initial recordable histological event in the development of sporadic conventional adenomas? Anticancer Res 38: 5315-5320, 2018. PMID: 30194183. DOI: 10.21873/anticanres.12858
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Smolle MA,
    2. Kashofer K,
    3. Riedl JM,
    4. Stotz M and
    5. Gerger A
    : Genetic analysis using a gene panel in 87 Caucasian patients with colorectal cancer: own results and review of literature. Anticancer Res 39: 847-852, 2019. PMID: 30711966. DOI: 10.21873/anticanres.13184
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Shimada Y,
    2. Kameyama H,
    3. Nagahashi M,
    4. Couper R,
    5. Davidson, Day A,
    6. Hammond P,
    7. Moore D and
    8. Thompson F,
    9. Ichikawa H,
    10. Muneoka Y,
    11. Yagi R,
    12. Tajima Y,
    13. Okamura T,
    14. Nakano M,
    15. Sakata J,
    16. Kobayashi T,
    17. Nogami H,
    18. Maruyama S,
    19. Takii Y,
    20. Hayashida T,
    21. Takaishi H,
    22. Kitagawa Y,
    23. Oki E,
    24. Konishi T,
    25. Ishida F,
    26. Kudo SE,
    27. Ring JE,
    28. Protopopov A,
    29. Lyle S,
    30. Ling Y,
    31. Okuda S,
    32. Ishikawa T,
    33. Akazawa K,
    34. Takabe K and
    35. Wakai T
    : Comprehensive genomic sequencing detects important genetic differences between right-sided and left sided colorectal cancer. Oncotarget 8: 93567-93579, 2017. PMID: 29212173. DOI: 10.18632/oncotarget.20510
    OpenUrlCrossRefPubMed
  13. ↵
    1. Li L,
    2. Weiss HL,
    3. Li J,
    4. Cheng Z,
    5. Donato L and
    6. Evers M
    : High plasma levels of pro-NT are associated with increased colon cancer risk. Endocr Relat Cancer 27: 641-646, 2020. PMID: 33055301. DOI: 10.1530/ERC-20-0310
    OpenUrlCrossRefPubMed
  14. ↵
    1. Bjornsdottir HH,
    2. Rawshani A,
    3. Rawshani A,
    4. Franzen S,
    5. Svensson A,
    6. Sattar N and
    7. Gudbjörnsdottir S
    : A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time. Sci Rep 10: 17376, 2020. PMID: 33060631. DOI: 10.1038/s41598-020-73668-y
    OpenUrlCrossRefPubMed
  15. ↵
    1. Joshi AD,
    2. Kim A,
    3. Lewinger JP,
    4. Joshi AD,
    5. Kim A and
    6. Lewinger JP
    : Meat intake, cooking methods, dietary carcinogens, and colorectal cancer risk: findings from the Colorectal Cancer Family Registry. Cancer Med 4: 936-952, 2015. PMID: 25846122. DOI: 10.1002/cam4.461
    OpenUrlCrossRefPubMed
  16. ↵
    1. Sobhani I,
    2. Rotkopf H and
    3. Khazaie K
    : Bacteria-related changes in host DNA methylation and the risk for CRC. Gut Microbes 12: 1800898, 2020. PMID: 32931352. DOI: 10.1080/19490976.2020.1800898
    OpenUrlCrossRefPubMed
  17. ↵
    1. Rubio CA and
    2. Schmidt PT
    : Severe defects in the macrophage barrier to gut microflora in inflammatory bowel disease and colon cancer. Anticancer Res 38: 3811-3815, 2018. PMID: 29970500. DOI: 10.21873/anticanres.12664
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Lao VV and
    2. Grady WM
    : Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 8: 686-700, 2011. PMID: 22009203. DOI: 10.1038/nrgastro.2011.173
    OpenUrlCrossRefPubMed
  19. ↵
    1. Fan C,
    2. Younis A,
    3. Bookhout CE and
    4. Crockett S
    : Management of serrated polyps of the colon. Curr Treat Options Gastroenterol 16: 182-202, 2018. PMID: 29445907. DOI: 10.1007/s11938-018-0176-0
    OpenUrlCrossRefPubMed
  20. ↵
    1. Konishi F and
    2. Morson BC
    : Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol 35: 830-841, 1982. PMID: 7107955. DOI: 10.1136/jcp.35.8.830
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Griffioen G,
    2. Bosman FT,
    3. Verspaget HW,
    4. De Bruin PA,
    5. Biemond I and
    6. Lamers CB
    : Solitary and synchronous adenomas of the colon and rectum: comparison of malignancy parameters. Histopathology 17: 529-535, 1990. PMID: 2076885. DOI: 10.1111/j.13652559.1990.tb00792.x
    OpenUrlCrossRefPubMed
  22. ↵
    1. Drew D,
    2. Nishihara R,
    3. Lochhead P,
    4. Kuchiba A,
    5. Qian ZR,
    6. Mima K,
    7. Nosho K,
    8. Wu K,
    9. Wang M,
    10. Giovannucci E,
    11. Fuchs CS,
    12. Chan AT and
    13. Ogino S
    : Prospective study of smoking and risk of synchronous colorectal. Cancers. Am J Gastroenterol 112: 493-501, 2017. PMID: 28117362. DOI: 10.1038/ajg.2016.589
    OpenUrlCrossRefPubMed
  23. ↵
    1. Slaughter, DP,
    2. Southwick, HW and
    3. Smejkal W
    : Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6: 963-968, 1953. PMID: 13094644. DOI: 10.1002/1097-0142(195309)6:5<963::aidcncr2820060515>3.0.co;2-q
    OpenUrlCrossRefPubMed
  24. ↵
    1. Park SK,
    2. Song C,
    3. Yang H,
    4. Jung YS,
    5. Choi KY,
    6. Koo DH,
    7. Kim KE,
    8. Jeong KU,
    9. Kim HO,
    10. Kim H,
    11. Chun HK and
    12. Park DI
    : Field cancerization in sporadic colon cancer. Gut Liver 10: 773-780, 2016. PMID: 27114416. DOI: 10.5009/gnl15334
    OpenUrlCrossRefPubMed
    1. Shen L,
    2. Kondo Y,
    3. Rosner GL,
    4. Shen L,
    5. Kondo Y,
    6. Rosner G,
    7. Xiao L,
    8. N, Vilaythong J,
    9. Houlihan J,
    10. Robert S. Krouse R,
    11. Prasad A,
    12. Einspahr J,
    13. Buckmeier J,
    14. Alberts D,
    15. Hamilton S and
    16. Issa JP
    : MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 97: 1330-1338, 2005. PMID: 16174854. DOI: 10.1093/jnci/dji275
    OpenUrlCrossRefPubMed
  25. ↵
    1. O’Reilly SL,
    2. McGlynn AP,
    3. McNulty H,
    4. O’Reilly SL,
    5. McGlynn AP and
    6. McNulty H
    : folic acid supplementation in postpolypectomy patients in a randomized controlled trial increases tissue folate concentrations and reduces aberrant DNA biomarkers in colonic tissues adjacent to the former polyp site. J Nutr 146: 933-939, 2016. PMID: 27075913. DOI: 10.3945/jn.115.222547
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Filipe MI and
    2. Branfoot AC
    : Abnormal patterns of mucus secretion in apparently normal mucosa of large intestine with carcinoma. Cancer 34: 282-290, 1974. PMID: 4850363. DOI: 10.1002/1097-0142(197408)34:2<282::aid-cncr2820340211>3.0.co;2-w
    OpenUrlCrossRefPubMed
  27. ↵
    1. Dawson P and
    2. Filipe I M
    : An ultrastructuraland histochemicalstudy of the mucous membraneadjecent to and remote from carcinoma of the colon. Cancer 37: 2388-2398, 1976. PMID: 177188. DOI: 10.1002/1097-0142(197605)37:5<2388::aid-cncr2820370531>3.0.co;2-9
    OpenUrlCrossRefPubMed
  28. ↵
    1. Cherkezyan L,
    2. Stypula-Cyrus Y,
    3. Subramanian Y,
    4. White C,
    5. Cruz M,
    6. Wali R,
    7. Goldberg M,
    8. Bianchi L,
    9. Roy H and
    10. Backman V
    : Nanoscale changes in chromatin organization represent the initial steps of tumorigenesis: a transmission electron microscopy study. BMC Cancer 14: 189-194, 2014. PMID: 24629088. DOI: 10.1186/1471-2407-14-189
    OpenUrlCrossRefPubMed
  29. ↵
    1. Facista A,
    2. Nguyen H,
    3. Lewis C,
    4. Prasad AR,
    5. Ramsey L,
    6. Zaitlin B,
    7. Nfonsam V,
    8. Krouse RS,
    9. Bernstein H,
    10. Payne CM,
    11. Stern S,
    12. Oatman N,
    13. Banerjee B and
    14. Bernstein C
    : Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer. Genome Integr 3: 3-10, 2012. PMID: 22494821. DOI: 10.1186/2041-9414-3-3
    OpenUrlCrossRefPubMed
  30. ↵
    1. Luo Y,
    2. Yu M and
    3. Grady W
    : Field cancerization in the colon: a role for aberrant DNA methylation? Gastroenterol Rep (Oxf) 2: 16-20, 2014. PMID: 24760232. DOI: 10.1093/gastro/got039
    OpenUrlCrossRefPubMed
    1. Nakajima T,
    2. Enomoto S and
    3. Ushijima T
    : DNA methylation: a marker for carcinogen exposure and cancer risk. Environ Health Prev Med 13: 8-15, 2008. PMID: 19568874. DOI: 10.1007/s12199-007-0005-x
    OpenUrlCrossRefPubMed
  31. ↵
    1. Boone PG,
    2. Rochelle LK,
    3. Ginzel JD,
    4. Boone P,
    5. Rochelle L,
    6. Ginzel J,
    7. Lubkov V,
    8. Roberts, Nicholls P,
    9. Bock C,
    10. Flowers ML,
    11. von Furstenberg R,
    12. Stripp B,
    13. Agarwal P,
    14. Borowsky A,
    15. Cardiff R,
    16. Barak L,
    17. Caron M,
    18. Lyerly H and
    19. Snyder J
    : A cancer rainbow mouse for visualizing the functional genomics of oncogenic clonal expansion. Nat Commun 10: 5490, 2019. PMID: 31792216. DOI: 10.1038/s41467-019-13330-y
    OpenUrlCrossRefPubMed
  32. ↵
    1. Galandiuk S,
    2. Rodriguez-Justo M,
    3. Jeffery R,
    4. Nicholson A,
    5. Cheng Y,
    6. Oukrif D,
    7. Elia G,
    8. Leedham S,
    9. McDonald S,
    10. Wright N and
    11. Graham T
    : Integrated transcriptomic analysis of distance-related field cancerization in rectal cancer patients. Field cancerization in the intestinal epithelium of patients with Crohn’s ileocolitis. Gastroenterology 142: 855-864, 2012. PMID: 28977850. DOI: 10.1053/j.gastro.2011.12.004
    OpenUrlCrossRefPubMed
  33. ↵
    1. Asada K,
    2. Ando T,
    3. Niwa T,
    4. Nanjo S,
    5. Watanabe N,
    6. Okochi-Takada E,
    7. Yoshida T,
    8. Miyamoto K,
    9. Enomoto S,
    10. Ichinosem M,
    11. Tsukamoto T,
    12. Ito S,
    13. Tatematsu M,
    14. Sugiyama T and
    15. Ushijima T
    : FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect. Oncogene 32: 2140-2149, 2013. PMID: 22689052. DOI: 10.1038/onc.2012.228
    OpenUrlCrossRefPubMed
  34. ↵
    1. Aivado M,
    2. Gynes M,
    3. Gorelov V,
    4. Schmidt W,
    5. Röher H and
    6. Goretzki P
    : Field cancerization-an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms. Chirurg 71: 1230-1234, 2000. PMID: 11077584. DOI: 10.1007/s001040051207
    OpenUrlCrossRefPubMed
  35. ↵
    1. Nevado L,
    2. Minguez P,
    3. Corton M,
    4. Casado S,
    5. Prieto I,
    6. Mas S,
    7. Sanz A,
    8. Alonso P,
    9. Villaverde C,
    10. Nuñez S,
    11. Aguilera O,
    12. Guerrero C,
    13. Esbrit P,
    14. Vivanco F,
    15. Gonzalez N,
    16. Ayuso C,
    17. Ortiz A,
    18. Rojo F,
    19. Egido J,
    20. Llamas G and
    21. Foncillas J
    : Molecular evidence of field cancerization initiated by diabetes in colon cancer patients. Mol Oncol 13: 857-72, 2019. PMID: 30628165. DOI: 10.1002/1878-0261.12438
    OpenUrlCrossRefPubMed
  36. ↵
    1. Kristt D,
    2. Winston G,
    3. Mellow M,
    4. Veltman V and
    5. Koren B
    : Patterns of proliferative changes in crypts bordering colonic tumors: zonal histology and cell cycle marker expression. Pathol Oncol Res 5: 297-303, 1999. PMID: 10607925. DOI: 10.1053/paor.1999.0207
    OpenUrlCrossRefPubMed
  37. ↵
    1. Rubio CA
    : Two histologic compartments in nonpolypoid conventional colon adenomas. J Gastroenterol Hepatol, 2020. PMID: 32757480. DOI: 10.1111/jgh.15210
    OpenUrlCrossRef
  38. ↵
    1. Shih IM,
    2. Wang TL,
    3. Traverso G,
    4. Romans K,
    5. Hamilton SR,
    6. Ben-Sasson S,
    7. Kinzler KW and
    8. Vogelstein B
    : Top-down morphogenesis of colorectal tumors Proc Natl Acad Sci USA 98: 2640-265, 2001. PMID: 11226292. DOI: 10.1073/pnas.051629398
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. Rubio CA and
    2. Schmidt PT
    : The normal epithelium of crypts accruing below nonpolypoid adenomas thrives with relocated proliferating cell-domains and p53-up-regulated cells. Anticancer Res 39: 4965-4970, 2019. PMID: 31519602. DOI: 10.21873/anticanres.13685
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Branfoot AC and
    2. Filipe MI
    : Failure to demonstrate specificity of the morphological and histochemical changes in mucosa adjacent to colonic carcinoma. J Clin Pathol 32: 852-858, 1979. PMID: 512045. DOI: 10.1136/jcp.32.8.852-a
    OpenUrlFREE Full Text
  41. ↵
    1. Humphries A,
    2. Cereser B,
    3. Gay L,
    4. Daniel S J
    5. Miller D,
    6. Bibek Das B,
    7. Alice Gutteridge A,
    8. George Elia G,
    9. Emma Nye E,
    10. Rosemary Jeffery R,
    11. Richard Poulsom R,
    12. Marco R,
    13. Novelli M,
    14. Justo M,
    15. McDonald S,
    16. Wright N and
    17. Graham T
    : Lineage tracing reveals multipotent stem cells maintain human adenomas and the pattern of clonal expansion in tumor evolution. PNAS USA 110: E24490-9, 2013. PMID: 23766371. DOI: 10.1073/pnas.1220353110
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Jackman RJ and
    2. Mayo CW
    : The adenoma-carcinoma sequence in cancer of the colon. Surg Gynecol Obstet 93: 327-330, 1951. PMID: 14866716.
    OpenUrlPubMed
  43. ↵
    1. Requena DO and
    2. Garcia-Buitrago M
    : Molecular insights into colorectal carcinoma. Arch Med Res S0188-4409(20)31738-0, 2020. PMID: 32962865. DOI: 10.1016/j.arcmed.2020.09.014
    OpenUrlCrossRef
    1. Kyrochristos ID and
    2. Roukos DH
    : Comprehensive intra-individual genomic and transcriptional heterogeneity: Evidence-based colorectal cancer precision medicine. Cancer Treat Rev 80: 101894, 2019. PMID: 31518831. DOI: 10.1016/j.ctrv.2019.101894
    OpenUrlCrossRefPubMed
    1. Coschi CH and
    2. Dick FA
    : Chromosome instability and deregulated proliferation: an unavoidable duo. Cell Mol Life Sci 69: 2009-2024, 2012. PMID: 22223110. DOI: 10.1007/s00018-011-0910-4
    OpenUrlCrossRefPubMed
  44. ↵
    1. Sun BL
    : Current microsatellite instability testing in management of colorectal cancer. Clin Colorectal Cancer S1533-0028(20)30104-3, 2020. PMID: 32888812. DOI: 10.1016/j.clcc.2020.08.001
    OpenUrlCrossRef
  45. ↵
    1. Baker AM,
    2. Gabbutt C,
    3. Williams, M,
    4. Cereser B,
    5. Jawad N,
    6. Justo M,
    7. Jansen M,
    8. Barnes C,
    9. Simons B,
    10. McDonald S,
    11. Graham T and
    12. Wright N
    : Crypt fusion as a homeostatic mechanism in the human colon. Gut 68: 1986-1993, 2019. PMID: 30872394. DOI: 10.1136/gutjnl-2018-317540
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Singh SR
    1. Rubio CA
    : Putative stem cells in mucosas of the esophago-gastrointestinal tract. In: Stem cell, regenerative medicine and cancer. Singh SR (ed.). Nova Science Publishers Inc.: New York 10, pp 279-308, 2010.
  47. ↵
    1. Baker AM and
    2. Graham T
    : Revealing human intestinal stem cell and crypt dynamics. Molec Cell Oncol 1: e970069-1-3, 2014. PMID: 27308359. DOI: 10.4161/23723548.2014.970069
    OpenUrlCrossRefPubMed
  48. ↵
    1. Fauser JK,
    2. Donato RP,
    3. Woenig JA,
    4. Proctor S,
    5. Trotta A,
    6. Grover P,
    7. Howarth G,
    8. Penttila I and
    9. Cummins A
    : Wnt blockade with dickkopf reduces intestinal crypt fission and intestinal growth in infant rats. Pediatr Gastroenterol Nutr 55: 26-31, 2012. PMID: 22193181. DOI: 10.1097/MPG.0b013e318246b42d
    OpenUrlCrossRef
  49. ↵
    1. Yamazaki M,
    2. Fujii E,
    3. Watanabe T,
    4. Kato A and
    5. Suzuki M
    : Histopathological evaluation of crypt fission during intestinal development in neonatal mice. J Toxicol Pathol 33: 39-46, 2020. PMID: 32051665. DOI: 10.1293/tox.2019-0032
    OpenUrlCrossRefPubMed
    1. Baker AM,
    2. Cereser B,
    3. Melton S,
    4. Fletcher AG,
    5. Rodriguez-Justo M,
    6. Tadrous PJ,
    7. Humphries A,
    8. Elia G,
    9. McDonald SAC,
    10. Wright NA,
    11. Simons BD,
    12. Jansen M and
    13. Graham TA
    : Quantification of crypt and stem cell evolution in the normal and neoplastic human colon. Cell Rep 8: 940-947, 2014 PMID: 31116993. DOI: 10.1016/j.celrep.2019.05.035
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 41 (3)
Anticancer Research
Vol. 41, Issue 3
March 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nondysplastic Crypts in Fission in Nonpolypoid Adenomas and in the Adjacent Mucosa Support Field Cancerization in the Colon
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Nondysplastic Crypts in Fission in Nonpolypoid Adenomas and in the Adjacent Mucosa Support Field Cancerization in the Colon
CARLOS A. RUBIO, PETER T. SCHMIDT
Anticancer Research Mar 2021, 41 (3) 1515-1521; DOI: 10.21873/anticanres.14910

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Nondysplastic Crypts in Fission in Nonpolypoid Adenomas and in the Adjacent Mucosa Support Field Cancerization in the Colon
CARLOS A. RUBIO, PETER T. SCHMIDT
Anticancer Research Mar 2021, 41 (3) 1515-1521; DOI: 10.21873/anticanres.14910
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Nondysplastic Colon Crypts Intercalated in Tubular Adenomas Support Field Cancerization
  • Further Study on Field Cancerization in the Human Colon
  • Crypts in Asymmetric Fission in Endoscopic Biopsies from German Patients With Inflammatory Bowel Disease
  • Google Scholar

More in this TOC Section

  • Comparison of BRCA2 Single Nucleotide Variants Between Japanese Patients With Familial Prostate Cancer, Sporadic Prostate Cancer, and Benign Prostatic Hyperplasia
  • Corrigendum
  • Sex-related Survival Differences in Patients With Glioblastoma – Results From a Retrospective Analysis
Show more Clinical Studies

Similar Articles

Keywords

  • Colon
  • field cancerization
  • nonpolypoid conventional adenomas
  • symmetric crypt fission
  • asymmetric crypt fission
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire